RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of
solutions designed to enhance the operational performance of its
customers through the deployment of advanced engineering, specialty
health care, and information technology services, today announced
financial results for the thirteen and twenty-six weeks ended June
29, 2024.
RCM Technologies reported revenue of $69.2 million
for the thirteen weeks ended June 29, 2024 (the current quarter),
an increase of 3.2% compared to $67.0 million for the thirteen
weeks ended July 1, 2023 (the comparable prior quarter). Gross
profit was $20.0 million for the current quarter, a 6.6% increase
compared to $18.8 million for the comparable prior quarter.
The Company experienced GAAP net income of $3.8 million, or $0.47
per diluted share, for the current quarter compared to $4.0
million, or $0.47 per diluted share, for the comparable prior
quarter. The Company experienced adjusted EBITDA (non-GAAP) of $7.2
million for the current quarter, a 10.8% increase compared to $6.5
million for the comparable prior quarter. The Company experienced
$0.56 of adjusted net income per diluted share (non-GAAP) for the
current quarter as compared to $0.50 for the comparable prior
quarter.
RCM Technologies reported revenue of $141.1
million for the twenty-six weeks ended June 29, 2024 (the current
period), an increase of 5.2% compared to $134.2 million for the
twenty-six weeks ended July 1, 2023 (the comparable prior-year
period). Gross profit was $40.4 million for the current period, a
6.8% increase compared to $37.8 million for the comparable
prior-year period. The Company experienced GAAP net income of
$7.7 million, or $0.95 per diluted share, for the current period
compared to $7.8 million, or $0.87 per diluted share, for the
comparable prior-year period. The Company experienced adjusted
EBITDA (non-GAAP) of $14.0 million for the current period, a 10.9%
increase compared to $12.6 million for the comparable prior-year
period. The Company experienced $1.10 of adjusted net income per
diluted share (non-GAAP) for the current period as compared to
$0.92 for the comparable prior-year period.
Bradley Vizi, Executive Chairman of RCM
Technologies, commented, “Second quarter growth was led by
Engineering, as project activity continues to ramp building on the
foundation carefully laid over the last several years.”
Kevin Miller, Chief Financial Officer of RCM
Technologies, commented, “Our strong cash generating business model
allows us to fund growth, while remaining opportunistic and
actively managing our capital structure.”
Conference Call On Thursday,
August 8, 2024, RCM Technologies will host a conference call to
discuss these results. The call will begin at 1:00 p.m. Eastern
Time. The dial-in number is (888) 272-8703.
About RCM RCM
Technologies (NasdaqGM: RCMT) is a business and technology
solutions provider with world-class talent in key market segments.
We help design, build, and enable the Industries of Tomorrow,
Today. Operating at the intersection of resources, critical
infrastructure and modernization of industries, RCM is a provider
of services in Health Care, Engineering, Aerospace & Defense,
Process & Industrial, Life Sciences and Data & Solutions.
www.rcmt.com.
The statements contained in this release that are
not purely historical are forward-looking statements within the
Private Securities Litigation Reform Act of 1995. They are subject
to various risks, uncertainties, and other factors that could cause
the Company’s actual results, performance, or achievements to
differ materially from those expressed or implied by such
forward-looking statements. These statements often include words
such as “may,” “will,” “expect,” “anticipate,” “continue,”
“estimate,” “project,” “intend,” “believe,” “plan,” “seek,”
“could,” “can,” “should,” “are confident” or similar expressions.
In addition, statements that are not historical should also be
considered forward-looking statements. These statements are based
on assumptions that we have made in light of our experience in the
industry, and our perceptions of historical trends, current
conditions, expected future developments, and other factors we
believe are appropriate in these circumstances. Forward-looking
statements include, but are not limited to, those relating to
demand for the Company’s services, expectations regarding our
future revenues and other financial results, such as cash flows,
our pipeline, and potential project wins, and our expectations for
investment and growth in our business. Such statements are based on
current expectations that involve several known and unknown risks,
uncertainties, and other factors, which may cause actual events to
be materially different from those expressed or implied by such
forward-looking statements. Risk, uncertainties, and other factors
may emerge from time to time that could cause the Company’s actual
results to differ from those indicated by the forward-looking
statements. Investors are directed to consider such risks,
uncertainties, and other factors described in documents filed by
the Company with the Securities and Exchange Commission, including
our most recent Annual Report on Form 10-K and subsequent Quarterly
Reports on Form 10-Q. The Company assumes no obligation (and
expressly disclaims any such obligation) to update any
forward-looking statements contained in this release as a result of
new information or future events or developments, except as may be
required by law.
RCM Technologies, Inc.
Condensed Consolidated Statements of Operations
(Unaudited) (In Thousands, Except Per
Share Amounts)
|
Thirteen Weeks Ended |
|
|
June 29,2024 |
|
July 1,2023 |
|
Revenue |
$69,164 |
|
$67,035 |
|
Cost of services |
|
49,163 |
|
|
48,275 |
|
Gross
profit |
|
20,001 |
|
|
18,760 |
|
Selling,
general and administrative |
|
13,545 |
|
|
12,723 |
|
Depreciation
and amortization of property and equipment |
|
332 |
|
|
242 |
|
Amortization
of acquired intangible assets |
|
46 |
|
|
46 |
|
Costs
associated with potential stock issuance |
|
259 |
|
|
- |
|
Operating
income |
|
5,819 |
|
|
5,749 |
|
Other
expense, net |
|
574 |
|
|
418 |
|
Income
before income taxes |
|
5,245 |
|
|
5,331 |
|
Income tax
expense |
|
1,483 |
|
|
1,348 |
|
Net
income |
$3,762 |
|
$3,983 |
|
|
|
|
|
|
Diluted net
earnings per share data |
$0.47 |
|
$0.47 |
|
Diluted
weighted average shares outstanding |
|
7,955,943 |
|
|
8,558,396 |
|
|
Twenty-Six Weeks Ended |
|
|
June 29,2024 |
|
July 1,2023 |
|
Revenue |
$141,103 |
|
$134,159 |
|
Cost of services |
|
100,735 |
|
|
96,375 |
|
Gross
profit |
|
40,368 |
|
|
37,784 |
|
Selling,
general and administrative |
|
27,744 |
|
|
26,119 |
|
Depreciation
and amortization of property and equipment |
|
619 |
|
|
513 |
|
Amortization
of acquired intangible assets |
|
91 |
|
|
91 |
|
Costs
associated with potential stock issuance |
|
259 |
|
|
- |
|
Gain on sale
of assets |
|
- |
|
|
(395 |
) |
Operating
income |
|
11,655 |
|
|
11,456 |
|
Other
expense, net |
|
1,000 |
|
|
825 |
|
Income
before income taxes |
|
10,655 |
|
|
10,631 |
|
Income tax
expense |
|
2,941 |
|
|
2,811 |
|
Net
income |
$7,714 |
|
$7,820 |
|
|
|
|
|
|
Diluted net
earnings per share data |
$0.95 |
|
$0.87 |
|
Diluted
weighted average shares outstanding |
|
8,078,049 |
|
|
8,976,714 |
|
RCM Technologies, Inc.
Supplemental Operating Results on a Non-GAAP Basis
(Unaudited) (In Thousands)
The following non-GAAP measures, which adjust for
the categories of expenses described below, are non-GAAP financial
measures. Our management believes that these non-GAAP
financial measures (“Adjusted operating income,” “EBITDA,”
“Adjusted EBITDA,” “Adjusted net income” and “Adjusted diluted net
earnings per share”) are useful information for investors,
shareholders, and other stakeholders of our Company in gauging our
results of operations on an ongoing basis and to enhance investors’
overall understanding of our current financial performance and
period-to-period comparisons. Adjusted operating income,
EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted
net earnings per share should not be considered alternatives to
operating income or net income, as the case may be, as an indicator
of performance. In addition, Adjusted operating income,
EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted
net earnings per share do not take into account changes in certain
assets and liabilities and interest and income taxes that can
affect cash flows. We do not intend the presentation of these
non-GAAP measures to be considered in isolation or as a substitute
for results prepared in accordance with GAAP. These non-GAAP
measures should be read-only in conjunction with our consolidated
financial statements prepared in accordance with GAAP.
The following unaudited table presents the
Company’s GAAP operating income and GAAP net income and the
corresponding adjustments used to calculate Adjusted operating
income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted
diluted net earnings per share for the thirteen and twenty-six
weeks ended June 29, 2024 and July 1, 2023.
|
Thirteen Weeks Ended |
|
Twenty-Six Weeks Ended |
|
|
June 29,2024 |
|
July 1,2023 |
|
June 29,2024 |
|
July 1,2023 |
|
|
(Unaudited) |
|
(Unaudited) |
|
(Unaudited) |
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
GAAP operating income |
$5,819 |
|
$5,749 |
|
$11,655 |
|
$11,456 |
|
Adjustments |
|
|
|
|
|
|
|
|
Gain on sale of assets |
|
- |
|
|
- |
|
|
- |
|
|
(395 |
) |
Costs associated with potential stock issuance |
|
259 |
|
|
- |
|
|
259 |
|
|
- |
|
Equity compensation |
|
752 |
|
|
471 |
|
|
1,387 |
|
|
967 |
|
Adjusted
operating income (non-GAAP) |
$6,830 |
|
$6,220 |
|
$13,301 |
|
$12,028 |
|
|
|
|
|
|
|
|
|
|
GAAP net
income |
$3,762 |
|
$3,983 |
|
$7,714 |
|
$7,820 |
|
Income tax
expense |
|
1,483 |
|
|
1,348 |
|
|
2,941 |
|
|
2,811 |
|
Interest
expense, net |
|
581 |
|
|
425 |
|
|
1,059 |
|
|
785 |
|
Depreciation
of property and equipment |
|
332 |
|
|
242 |
|
|
619 |
|
|
513 |
|
Amortization
of acquired intangible assets |
|
46 |
|
|
46 |
|
|
91 |
|
|
91 |
|
EBITDA
(non-GAAP) |
$6,204 |
|
$6,044 |
|
$12,424 |
|
$12,020 |
|
|
|
|
|
|
|
|
|
|
Adjustments |
|
|
|
|
|
|
|
|
Gain on sale of assets |
|
- |
|
|
- |
|
|
- |
|
|
(395 |
) |
Costs associated with potential stock issuance |
|
259 |
|
|
- |
|
|
259 |
|
|
- |
|
(Gain) loss on foreign currency transactions |
|
(7 |
) |
|
(7 |
) |
|
(59 |
) |
|
40 |
|
Equity compensation |
|
752 |
|
|
471 |
|
|
1,387 |
|
|
967 |
|
Adjusted
EBITDA (non-GAAP) |
$7,208 |
|
$6,508 |
|
$14,011 |
|
$12,632 |
|
RCM Technologies, Inc.
Supplemental Operating Results on a Non-GAAP Basis
(Continued) (Unaudited) (In
Thousands)
|
Thirteen Weeks Ended |
|
Twenty-Six Weeks Ended |
|
|
June 29,2024 |
|
July 1,2023 |
|
June 29,2024 |
|
July 1,2023 |
|
|
(Unaudited) |
|
(Unaudited) |
|
(Unaudited) |
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
GAAP net income |
$3,762 |
|
$3,983 |
|
$7,714 |
|
$7,820 |
|
Adjustments |
|
|
|
|
|
|
|
|
Gain on sale of assets |
|
- |
|
|
- |
|
|
- |
|
|
(395 |
) |
Costs associated with potential stock issuance |
|
259 |
|
|
- |
|
|
259 |
|
|
- |
|
(Gain) loss on foreign currency transactions |
|
(7 |
) |
|
(7 |
) |
|
(59 |
) |
|
40 |
|
Equity compensation |
|
752 |
|
|
471 |
|
|
1,387 |
|
|
967 |
|
Tax impact from normalized rate |
|
(276 |
) |
|
(128 |
) |
|
(444 |
) |
|
(168 |
) |
Adjusted net
income (non-GAAP) |
$4,490 |
|
$4,319 |
|
$8,857 |
|
$8,264 |
|
|
|
|
|
|
|
|
|
|
GAAP diluted
net earnings per share |
$0.47 |
|
$0.47 |
|
$0.95 |
|
$0.87 |
|
Adjustments |
|
|
|
|
|
|
|
|
Gain on sale of assets |
|
- |
|
|
- |
|
|
- |
|
($0.04 |
) |
Costs associated with potential stock issuance |
$0.03 |
|
|
- |
|
$0.03 |
|
|
- |
|
(Gain) loss on foreign currency transactions |
|
- |
|
|
- |
|
|
- |
|
$0.01 |
|
Equity compensation |
$0.09 |
|
$0.05 |
|
$0.17 |
|
$0.10 |
|
Tax impact from normalized rate |
($0.03 |
) |
($0.02 |
) |
($0.05 |
) |
($0.02 |
) |
Adjusted
diluted net earnings per share (non-GAAP) |
$0.56 |
|
$0.50 |
|
$1.10 |
|
$0.92 |
|
RCM Technologies, Inc.
Summary of Selected Income Statement Data
(Unaudited) (In Thousands)
|
Thirteen Weeks Ended June 29, 2024 |
|
|
SpecialtyHealth Care |
|
Engineering |
|
Life Sciencesand IT |
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
Revenue |
$36,932 |
|
$22,508 |
|
$9,724 |
|
$69,164 |
|
Cost of services |
|
26,293 |
|
|
16,542 |
|
|
6,328 |
|
|
49,163 |
|
Gross
profit |
$10,639 |
|
$5,966 |
|
$3,396 |
|
$20,001 |
|
Gross profit
margin |
|
28.8 |
% |
|
26.5 |
% |
|
34.9 |
% |
|
28.9 |
% |
|
Thirteen Weeks Ended July 1, 2023 |
|
|
SpecialtyHealth Care |
|
Engineering |
|
Life Sciencesand IT |
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
Revenue |
$35,528 |
|
$21,014 |
|
$10,493 |
|
$67,035 |
|
Cost of services |
|
25,727 |
|
|
16,192 |
|
|
6,356 |
|
|
48,275 |
|
Gross
profit |
$9,801 |
|
$4,822 |
|
$4,137 |
|
$18,760 |
|
Gross profit
margin |
|
27.6 |
% |
|
22.9 |
% |
|
39.4 |
% |
|
28.0 |
% |
|
Twenty-Six Weeks Ended June 29, 2024 |
|
|
SpecialtyHealth Care |
|
Engineering |
|
Life Sciencesand IT |
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
Revenue |
$75,114 |
|
$46,013 |
|
$19,976 |
|
$141,103 |
|
Cost of services |
|
53,409 |
|
|
34,540 |
|
|
12,786 |
|
|
100,735 |
|
Gross
profit |
$21,705 |
|
$11,473 |
|
$7,190 |
|
$40,368 |
|
Gross profit
margin |
|
28.9 |
% |
|
24.9 |
% |
|
36.0 |
% |
|
28.6 |
% |
|
Twenty-Six Weeks Ended July 1, 2023 |
|
|
SpecialtyHealth Care |
|
Engineering |
|
Life Sciencesand IT |
|
Consolidated |
|
|
|
|
|
|
|
|
|
|
Revenue |
$74,658 |
|
$39,504 |
|
$19,997 |
|
$134,159 |
|
Cost of services |
|
53,185 |
|
|
30,365 |
|
|
12,555 |
|
|
96,375 |
|
Gross
profit |
$21,473 |
|
$8,869 |
|
$7,442 |
|
$37,784 |
|
Gross profit
margin |
|
28.8 |
% |
|
22.5 |
% |
|
37.2 |
% |
|
28.2 |
% |
RCM Technologies, Inc.
Condensed Consolidated Balance Sheets
(Unaudited) (In Thousands, Except Share
Amounts)
|
June 29, |
|
December 30, |
|
|
2024 |
|
2023 |
|
|
(Unaudited) |
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
$3,480 |
|
$6,284 |
|
|
Accounts receivable, net of provision for credit losses of $1,600on
June 29, 2024 and December 30, 2023 |
|
66,915 |
|
|
70,690 |
|
|
Transit accounts receivable |
|
9,460 |
|
|
8,891 |
|
|
Prepaid expenses and other current assets |
|
5,432 |
|
|
4,637 |
|
|
|
Total current assets |
|
85,287 |
|
|
90,502 |
|
|
|
|
|
|
|
|
Property and equipment, net |
|
4,451 |
|
|
4,005 |
|
|
|
|
|
|
Deposits |
|
203 |
|
|
313 |
|
Deferred income taxes, foreign |
|
53 |
|
|
55 |
|
Goodwill |
|
22,147 |
|
|
22,147 |
|
Operating right of use asset |
|
5,545 |
|
|
2,779 |
|
Intangible assets, net |
|
592 |
|
|
683 |
|
|
|
Total other
assets |
|
28,540 |
|
|
25,977 |
|
|
|
|
|
|
|
|
|
|
Total
assets |
$118,278 |
|
$120,484 |
|
Current liabilities: |
|
|
|
|
|
Accounts payable and accrued expenses |
$12,917 |
|
$12,454 |
|
|
Transit accounts payable |
|
30,925 |
|
|
31,102 |
|
|
Accrued payroll and related costs |
|
9,710 |
|
|
11,203 |
|
|
Finance lease payable |
|
- |
|
|
233 |
|
|
Income taxes payable |
|
136 |
|
|
330 |
|
|
Operating right of use liability |
|
983 |
|
|
693 |
|
|
Contingent consideration from acquisitions |
|
300 |
|
|
300 |
|
|
Deferred revenue |
|
2,678 |
|
|
1,881 |
|
|
|
Total current liabilities |
|
57,649 |
|
|
58,196 |
|
|
|
|
|
|
Deferred income taxes, net, foreign |
|
183 |
|
|
187 |
|
Deferred income taxes, net, domestic |
|
1,669 |
|
|
1,568 |
|
Contingent consideration from acquisitions, net of current
position |
|
1,671 |
|
|
1,671 |
|
Operating right of use liability, net of current position |
|
4,784 |
|
|
2,268 |
|
Borrowings under line of credit |
|
23,870 |
|
|
30,804 |
|
|
Total
liabilities |
|
89,826 |
|
|
94,694 |
|
|
|
|
|
|
Contingencies (note 15) |
|
- |
|
|
- |
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
Preferred stock, $1.00 par value; 5,000,000 shares authorized; |
|
|
|
|
|
|
no shares
issued or outstanding |
|
- |
|
|
- |
|
|
Common stock, $0.05 par value; 40,000,000 shares authorized; |
|
|
|
|
|
|
17,775,693
shares issued and 7,666,709 shares outstanding atJune 29, 2024 and
17,673,427 shares issued and 7,844,821 sharesoutstanding at
December 30, 2023 |
|
887 |
|
|
882 |
|
|
Additional paid-in capital |
|
117,008 |
|
|
116,579 |
|
|
Accumulated other comprehensive loss |
|
(2,908 |
) |
|
(2,813 |
) |
|
Accumulated deficit |
|
(11,551 |
) |
|
(19,265 |
) |
|
Treasury stock, 10,108,984 shares at June 29, 2024 and |
|
|
|
|
|
|
9,828,606
shares at December 30, 2023, at cost |
|
(74,984 |
) |
|
(69,593 |
) |
|
|
Total
stockholders’ equity |
|
28,452 |
|
|
25,790 |
|
|
|
|
|
|
|
|
|
|
Total
liabilities and stockholders’ equity |
$118,278 |
|
$120,484 |
|
RCM Technologies, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited) (In Thousands)
|
Thirteen Weeks Ended |
|
|
June 29, 2024 |
|
July 1, 2023 |
|
Net income |
$3,762 |
|
$3,983 |
|
Adjustments to reconcile net income to cash used in operating
activities |
|
1,442 |
|
|
1,043 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
Accounts receivable |
|
6,628 |
|
|
(2,804 |
) |
|
Prepaid
expenses and other current assets |
|
(916 |
) |
|
(648 |
) |
|
Net of
transit accounts receivable and payable |
|
(527 |
) |
|
19,356 |
|
|
Accounts
payable and accrued expenses |
|
(660 |
) |
|
654 |
|
|
Accrued
payroll and related costs |
|
(2,462 |
) |
|
(3,598 |
) |
|
Right of use
liabilities |
|
(154 |
) |
|
(335 |
) |
|
Income taxes
payable |
|
(638 |
) |
|
6 |
|
|
Deferred
revenue |
|
(836 |
) |
|
(305 |
) |
|
Deposits |
|
86 |
|
|
(9 |
) |
Total adjustments |
|
1,963 |
|
|
13,360 |
|
Net cash provided by (used in) operating activities |
$5,725 |
|
$17,343 |
|
|
|
|
|
|
Net cash used in investing activities |
|
(398 |
) |
|
(227 |
) |
Net cash used in financing activities |
|
(3,796 |
) |
|
(17,631 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
(150 |
) |
|
(37 |
) |
Increase (decrease) in cash and cash equivalents |
$1,381 |
|
($552 |
) |
|
Twenty-Six Weeks Ended |
|
|
June 29,2024 |
|
July 1,2023 |
|
Net income |
$7,714 |
|
$7,820 |
|
Adjustments to reconcile net income to cashused in operating
activities |
|
2,692 |
|
|
1,746 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
Accounts receivable |
|
3,826 |
|
|
(10,839 |
) |
|
Prepaid
expenses and other current assets |
|
(796 |
) |
|
312 |
|
|
Net of
transit accounts receivable and payable |
|
(746 |
) |
|
20,828 |
|
|
Accounts
payable and accrued expenses |
|
685 |
|
|
(1,013 |
) |
|
Accrued
payroll and related costs |
|
(1,486 |
) |
|
(1,194 |
) |
|
Right of use
liabilities |
|
(458 |
) |
|
(683 |
) |
|
Income taxes
payable |
|
(187 |
) |
|
147 |
|
|
Deferred
revenue |
|
797 |
|
|
(615 |
) |
|
Deposits |
|
110 |
|
|
2 |
|
Total adjustments |
|
4,437 |
|
|
8,691 |
|
Net cash provided by operating activities |
$12,151 |
|
$16,511 |
|
|
|
|
|
|
Net cash used in investing activities |
|
(1,067 |
) |
|
(559 |
) |
Net cash used in financing activities |
|
(13,510 |
) |
|
(15,215 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
(378 |
) |
|
197 |
|
(Decrease) increase in cash and cash equivalents |
($2,804 |
) |
$934 |
|
RCM
Technologies, Inc. |
|
|
|
Tel:
856.356.4500 |
|
|
|
|
|
Corporate Contacts: |
2500 McClellan Avenue |
|
|
|
info@rcmt.com |
|
|
|
|
|
Bradley S. Vizi |
Pennsauken, NJ 08109 |
|
|
|
www.rcmt.com |
|
|
|
|
|
Executive Chairman |
|
|
|
|
|
|
|
|
|
|
Kevin D. Miller |
|
|
|
|
|
|
|
|
|
|
Chief Financial Officer |
RCM Technologies (NASDAQ:RCMT)
過去 株価チャート
から 10 2024 まで 11 2024
RCM Technologies (NASDAQ:RCMT)
過去 株価チャート
から 11 2023 まで 11 2024